Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,331,000 | 2,333,000 | 2,486,000 | 2,453,000 | 2,611,000 |
| Cost of Goods | 1,560,000 | 1,575,000 | 1,618,000 | 1,611,000 | 1,646,000 |
| Gross Profit | 771,000 | 758,000 | 868,000 | 842,000 | 965,000 |
| Operating Expenses | 466,000 | 623,000 | 476,000 | 454,000 | 452,000 |
| Operating Income | 305,000 | 135,000 | 392,000 | 388,000 | 513,000 |
| Interest Expense | 35,000 | 32,000 | 33,000 | 36,000 | 37,000 |
| Other Income | 12,000 | 9,000 | -2,000 | -25,000 | 7,000 |
| Pre-tax Income | 282,000 | 112,000 | 357,000 | 327,000 | 483,000 |
| Income Tax | 65,000 | -4,000 | 81,000 | 77,000 | 110,000 |
| Net Income Continuous | 217,000 | 116,000 | 276,000 | 250,000 | 373,000 |
| Minority Interests | 15,000 | 15,000 | 20,000 | 16,000 | 18,000 |
| Net Income | $202,000 | $101,000 | $256,000 | $234,000 | $355,000 |
| EPS Basic Total Ops | 1.80 | 0.93 | 2.20 | 2.00 | 2.97 |
| EPS Basic Continuous Ops | 1.94 | 1.10 | 2.38 | 2.14 | 3.13 |
| EPS Diluted Total Ops | 1.78 | 0.92 | 2.17 | 1.96 | 2.92 |
| EPS Diluted Continuous Ops | 1.92 | 1.08 | 2.34 | 2.10 | 3.08 |
| EBITDA(a) | $412,000 | $251,000 | $500,000 | $495,000 | $619,000 |